The issue of shorting has been extensively addressed by Clinuvel in the past. They threatened to initiate legal proceedings against frustrated longtime shareholders who dared post their grievances or exercise their rights to vote against resolutions. They organized an online editorial in the FT claiming that they had beaten the shorters. They continued to support the overpaid and underperforming executive team.
What they didn’t do was invest confidently and aggressively in growing their revenue. The rollout has stalled in EU, slowed in US and non existent elsewhere. The XP indication has stalled due to unimpressive results, the topical M line doesn’t exist, ACTH has no market and no synergies, stroke is a 1:100,000 shot. Vitiligo will probably work but is 12 years too late.
Disc Medicine - Best comparison stock to Clinuvel, page-38
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.65 |
Change
0.590(3.92%) |
Mkt cap ! $783.7M | |||
| Open | High | Low | Value | Volume |
| $15.27 | $15.65 | $15.05 | $967.0K | 62.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 227 | $15.48 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.65 | 999 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |